Article Details
Retrieved on: 2022-05-21 15:19:55
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
“Adacanumab, the monoclonal antibody which the FDA approved for use in the mild neurocognitive stage in Alzheimer's disease, but it generated a ...
Article found on: www.hcplive.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here